[London, 31 August 2023] – With Augnito voice-driven AI transcription capabilities now integrated into the OpenRad Cloud (by Biotronics3D), its English speaking users will benefit from the increased efficiency and functionality that Augnito’s native speech reporting offers.

Scribetech today announced the successful integration of Augnito Voice Services™, an AI-powered voice-driven speech recognition API/SDK, into OpenRad Cloud (by Biotronics3D) – a remote radiology reporting platform.

OpenRad is a supplier of innovative radiology solutions for static and mobile diagnostic imaging centres worldwide, empowering healthcare professionals and the wider clinical research community with fully digitalised workflow processes that connect people, technology, and data.

Augnito is a secure and portable clinical speech recognition suite that offers medical professionals highly accurate, fast, effortless ways to dictate and transcribe live clinical data, on any mobile or desktop device – without the need for typing or outsourced services. For integrators and systems developers, Augnito delivers effective speech-enablement and voice-driven capability to many applications and clinical systems.

With the Augnito Voice Services API/SDK integrated into the cloud-based reporting platform, OpenRad can assist a severely understaffed and overworked profession with time-saving, highly accurate speech recognition technology. The combined solution means radiologists can accommodate increasing workloads and ever-expanding levels of diagnostic reporting from wherever they have an internet connection.

By speech-enabling the OpenRad Cloud reporting solution, Augnito delivers enhanced value, increased efficiency, and clinical data accuracy to OpenRad’s thousands of reporters. As well as making workloads more manageable, this also positively impacts the patient journey – from diagnosis to hospital stays – with an improved more seamless continuum of care.

OpenRad has also selected to add Augnito Spectra as a standalone “off the shelf” speech recognition product to its solution offering. The two Augnito products address multiple technology challenges previously experienced by OpenRad reporters. Many of these issues were the result of legacy non-interoperable products that are effective in isolation, but do not work so well together as one cohesive workflow.

Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito stated: “Augnito is a disruptive innovation technology that carries Scribetech’s commitment to data accuracy along with our strong 20+ year heritage of delivering digital dictation solutions and transcription services to the NHS. It brings speech recognition to the clinical healthcare professionals who need it the most, alleviating clinical risk, cutting costs, and avoiding difficult and time-consuming upgrades on legacy systems.”

“In the UK, we look to provide Augnito speech recognition through a highly selective network of best in breed partners that share our approach to developing solutions that embrace AI innovation to enhance healthcare intelligence. OpenRad solidifies this strategy.”

“Augnito will augment the existing support and reporting benefits that our cloud-based reporting platform offers radiologists in the public and private healthcare system across the UK and English-speaking countries. This integration enables OpenRad to expand on its mission to transform healthcare through an open diagnostic network. At OpenRad we put patient outcomes first by speeding up clinical decision-making through the seamless connection and collaboration of healthcare experts, imaging providers, referrers, and their patients.” stated Brian Plackis Cheng, CEO of OpenRad.

ENDS

For media enquiries, please contact [email protected]

Notes to editors

About Scribetech (UK) Ltd and Augnito
Scribetech (UK) Ltd is a clinical solutions innovator and official distributor of Augnito products in the UK and Ireland. The company co-developed Augnito with its sister company Augnito India Private Ltd fusing 20 years of highly accurate and secure transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own Deep Neural Network speech recognition engine with advanced voice AI technology. Augnito provides a secure, cloud-based, voice-driven AI clinical speech recognition product suite, offering fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings cost effective, seamless speech recognition to daily workflows and third-party clinical systems, quickly turning medical information into documentation that makes healthcare intelligence compliant and accessible where it is needed. Visit www.scribetech.co.uk for more details.

About OpenRad
Founded in 2021 and based in London and Berlin, OpenRad delivers innovative radiology solutions for static and mobile diagnostic imaging centres worldwide. OpenRad aims to empower healthcare professionals and the wider research community by connecting people, technology, and data.
By combining the intelligent products and services of previously acquired Biotronics3D and Visbion, OpenRad can fully digitalise the workflow processes within the radiological diagnostic sphere. Its zero footprint SaaS based solutions speed up implementation, increase centre utilisation, provide remote access, and reduce cost of ownership. Visit www.openrad.com for further information.

OpenRad integrates and sells Augnito speech recognition

[London, 30 June 2023] – Scribetech has been dramatically expanding its ecosystem of Augnito partnerships and successful integrations in order to empower more healthcare professionals with clinical documentation flexibility and a more efficient way of working.

Efficient clinical speech/voice-to-text digital dictation technology has the potential to improve clinical workflows, reduce delayed patient journeys and enable better informed outcomes. Such technology is only as effective as it is accessible, easy to adopt, easy to integrate, and easy to use.

To this end Scribetech (UK) Ltd, co-creator of Augnito, has invested in a new ecosystem of distributors, value added resellers and integration partners to help bring its AI-powered speech recognition technology to more users across the UK, starting with the new channel’s customers.

In the past three months, companies have been onboarded as distributors for Augnito Spectra – a cloud-based clinical speech recognition solution that supports any English accent, out of the box. This recent UK activity follows successful agreements with resellers in the last quarter. In addition, integration partners including Aptvision, OpenRad and Intelerad have recently integrated Augnito Voice Services into their own radiology reporting platforms, bringing higher levels of accuracy and the time-saving advantage of speech to the systems their respective medical customers already use.

This recent success aligns with Augnito’s sales and development team’s core strategy, reflecting not only a strong 2-year track record in delivering measurable savings and benefits to healthcare, but also reiterating the premier service-oriented heritage it carries from its co-developer’s solution support to the NHS in the last two decades.

More than 12,000 doctors across 355 hospitals and 24 partners in UK, USA, Canada, India, the Middle East and APAC, have signed up to Augnito in just 24 months. They are joined by 1500 radiologists and a growing number of consultants at various NHS Trusts. “Everything comes back to the mission we set out when we launched Augnito in the UK in late 2021,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito.

“We know that when access to technology is simplified from the ground up, even small increases in performance turn into huge savings. Those savings can be repurposed into what matters most – making healthcare professionals efficient at delivering exceptional care and improving patient outcomes.”

Interoperability and integration are both key to this important goal. Through Augnito Voice Services and a flexible API/SDK, healthcare technology providers can integrate speech recognition into their own platforms in a matter of weeks. To date, Cimar UK, Hexarad, Fujifilm UK Medical Systems and Magentus have all integrated Augnito technology into their radiology systems, enabling efficient workflows for their customers with more accurate diagnostic reporting.

Augnito Spectra gives users constant access to accurate speech recognition and live data input on any device running either Windows or MAC operating systems. This data is then routed securely to clinical systems including PACS and EPRs. Augnito’s ability to fit into existing clinical workflows makes user adoption easier and effective. It reduces both workload management and costs, as well as changing the way providers deploy new technology – ground up vs. top down.

Austin added: “Through our best-in-breed partnerships, we’re introducing real product flexibility and agility to assist medical health professionals in providing better patient journeys. We’ve been proactive in creating more ways to use Augnito, helping us align to the NHS plan for digital transformation and ensure new technology is integrated in a way that will naturally drive user adoption.”

For IT and technology providers in healthcare, Augnito Spectra carries a compelling (up to) 30% profit margin on every UK licence the partner sells. It is designed to be easy and fast to deploy and looks to complement partners’ existing product portfolios and service offerings. For partners’ users, Augnito Spectra provides simpler and more accurate clinical data input into all major EPR systems.

Austin concluded: “We’ve seen significant demand from resellers because the demand is there across healthcare. Inefficiencies and reporting bottlenecks are costing millions of pounds in Delayed Transfer of Care (DTOC) and bed costs as well as the ever growing patient waiting lists. And with rising demand and intense workloads, everyone inside a Trust knows something needs to change. The healthcare user benefits and the time and financial savings are significant from day one. In fact the cost of Augnito per day is less than a takeaway coffee.”

ENDS

Notes to editors

About Augnito and Scribetech
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible everywhere.

Augnito was co-developed by Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology.

[London, 21 June 2022] – With an open API and fast integration, Augnito’s AI-powered speech recognition engine makes Hexarad’s radiology reporting platform faster, easier to use and more accurate.

With widespread NHS staff shortages and increased pressure to provide fast, error-free imaging reporting, the technology that supports radiologists is constantly evolving. Now, Hexarad – one of the UK’s leading radiology platform providers – has adopted Augnito: an innovative, AI-based medical speech recognition solution.

With Augnito’s proven speech recognition in the cloud, Hexarad’s speech-enabled platform empowers radiologists with a faster, more flexible way of reporting.

Developed in partnership with clinicians, Augnito gives radiologists fast, easy ways to capture live clinical data on any device with 99.3% accuracy. This is made possible by a sophisticated, AI-driven engine that intelligently and accurately captures patient data in any accent, including medical and clinical terms. Available in the cloud, adopting Augnito is quick, easy and requires no on-premise hardware or in-house support and maintenance.

Crucially, Augnito understands the way radiologists need to work and the importance of speech recognition that’s deeply integrated with other clinical systems.

“Beyond our user-suite of applications, Augnito includes a comprehensive API and SDK, allowing clinical systems to easily become speech enabled,” says Shiraz Austin, Co-Founder and Managing Director at Scribetech (UK) Ltd. “It’s important to us that the time-saving benefits of speech recognition are accessible to as many healthcare professionals as possible, even in the familiar systems they’re already using. Our partnership with Hexarad is a great example of two best-in-class technologies working seamlessly together.”

The Augnito API allowed Hexarad to replace an existing speech recognition solution and embed accurate, real-time speech-to-text data entry into its radiology reporting platform, Optirad. The API also provides better support for integrating voice commands, saving radiologists time every day.

For Hexarad, Augnito offered the right blend of accurate technology and fast, flexible integration.

“Augnito did exactly what we needed it to do, seamlessly and efficiently,” says Dr Jaymin Patel, Chief Operating Officer for Hexarad. “The integration provided a rapid deployment and roll-out for us, taking a total of just 12 weeks. The API was outstanding and entirely customisable to our needs.”

Today, Hexarad is using Augnito to support all 60 of its radiologists, enabling them to spend more time on the detailed analysis of patients’ scans as well as increasing the number of scans and reports they complete, without compromising on accuracy. This creates a better way of working, decreases the pressure from growing workloads and, ultimately, helps patients get the diagnoses they need sooner.

ENDS

NOTES TO EDITORS
For further information, interview opportunities or accompanying graphics please contact: Georgina Pavelin, Mixed Media, [email protected]

About Scribetech and Augnito
Scribetech (UK) Ltd is a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text and clinical coding solutions for the healthcare sector, and its own speech recognition engine and advanced voice AI technology.

Augnito is Scribetech’s secure, cloud-based and AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99.3% accuracy, support for multiple medical specialties, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible, everywhere. www.scribetech.co.uk/augnito-speechrecognition

About Hexarad
Hexarad is a leading radiology platform based across the UK and Ireland. Its bespoke built-in workflow management software solution, Optirad, helps hospitals manage their own radiology resources better, improve productivity and efficiency allowing team leaders to deliver patient -centred service with timely and accurate scan reporting to streamline departments and existing resources. They also provide a full service teleradiology solution to ensure fast, accurate diagnosis for everyone, everywhere.